Alteplase improves stroke recovery by over 50% when given up to 24 hours after symptom onset, offering hope for patients with ...
Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
In a randomized clinical trial, giving the clot-busting medication alteplase up to 24 hours after stroke symptoms first appeared increased the odds of better recovery by 50% compared to those who ...
More than 100 million people globally have had a stroke, but there are ways to reduce your risk and spot the signs of stroke ...
Prehospital measurement of glial fibrillary acidic protein (GFAP) can rapidly differentiate intracerebral hemorrhage (ICH) from ischemic stroke (IS) and stroke mimics.
20h
News Medical on MSNESCAPE-MeVO trial advances understanding of stroke treatment for medium-sized vessel blockagesUniversity of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke.
University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...
LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...
The severity of left ventricular diastolic dysfunction affects risk for incident stroke and transient ischemic attack, as well as major bleeding.
MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results